Clinical Trials Directory

Trials / Completed

CompletedNCT03277339

Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders

Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders (Insula-TOP)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Centre Hospitalier Henri Laborit · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Multicenter study comparing paroxetine (n=30) versus thermal cure (n=30) in patients with a diagnosis of Generalised Anxiety Disorders

Detailed description

Multicenter study comparing paroxetine (n=30) versus thermal cure (n=30) in patients with a diagnosis of Generalised Anxiety Disorders Main objective is to quantify the therapeutic benefit of a thermal cure on generalized anxiety disorders and to understand the psycho-biological substrates of this improvement. Secondary objectives: * A decrease of Insula activity at rest during the answers to aversive pictures and during the task of subjective measurement of heartbeat. * A decrease of sensibility to emotional interference by subliminal presentation of emotional words thanks to a lexical task and a color recognition task associated to simultaneous measurement of physiological indicator of emotional activity ( dermal resistance)

Conditions

Interventions

TypeNameDescription
DRUGParoxetineDeroxat® (20 mg/day) 3 week; can be increase on week 2 until 50 mg.
OTHERThermal cureThermal cure is realized for 3 weeks

Timeline

Start date
2017-01-19
Primary completion
2020-01-08
Completion
2020-02-05
First posted
2017-09-11
Last updated
2022-10-12

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03277339. Inclusion in this directory is not an endorsement.